⚙
AI-generated summary
by gemini-2.5-flash-lite, 2026-07-16
ⓘ
This paper reviews the diagnostic and therapeutic approach to abnormal uterine bleeding, detailing its causes, the FIGO PALM-COEIN classification, and management strategies for various patient populations.
⚙
AI-generated deep summary
by claude@2026-07, 2026-07-16
· read from full text
ⓘ
This paper reviews abnormal uterine bleeding across the lifespan, outlining how disrupted menstrual physiology (hormonal imbalance, impaired endometrial hemostasis, abnormal angiogenesis, and structural pathology) can produce excessive, irregular, or prolonged bleeding, and how the presentation may be acute or chronic. It describes a diagnostic framework using the FIGO PALM–COEIN classification, combining history, examination, labs to assess anemia and systemic causes, transvaginal ultrasound for structural abnormalities, and endometrial sampling for patients at increased risk, while also noting specific age-related etiologic patterns and the need for attention to postmenopausal bleeding due to malignancy risk. It presents a stepwise, individualized management approach that prioritizes medical options and reserves surgical or interventional treatments for refractory or severe cases, including considerations for adolescents and perimenopausal women as special populations. Relevance to endometriosis: adenomyosis is explicitly discussed as a structural cause becoming more prevalent in the perimenopausal period, though the paper is a general review of abnormal uterine bleeding rather than an endometriosis-focused study.
Abstract
Abnormal uterine bleeding is a frequent gynecological condition with a significant impact on women’s health across the lifespan. It arises from complex alterations in normal menstrual physiology, including hormonal imbalance, impaired endometrial hemostasis, abnormal angiogenesis, and structural uterine pathology. Under physiological conditions, coordinated fluctuations of estrogen and progesterone regulate endometrial proliferation, differentiation, and shedding, while effective hemostatic mechanisms limit menstrual blood loss. Disruption of these processes leads to excessive, irregular, or prolonged bleeding. Clinically, abnormal uterine bleeding may present as acute or chronic disease, a distinction that guides diagnostic urgency and therapeutic decision-making. Its etiology varies according to age, with ovulatory dysfunction predominating in adolescents and younger women, and structural causes such as polyps, fibroids, and adenomyosis becoming more prevalent during the perimenopausal period. Postmenopausal bleeding warrants particular attention because of its association with endometrial malignancy. The FIGO PALM–COEIN classification system provides a standardized framework to distinguish structural from non-structural causes and supports a systematic diagnostic approach. Evaluation of abnormal uterine bleeding relies on detailed clinical history, characterization of bleeding patterns, physical and gynecological examination, and identification of red flags suggestive of malignancy. Diagnostic assessment integrates laboratory testing to exclude anemia and systemic disorders, imagingprimarily transvaginal ultrasoundto identify structural abnormalities, and endometrial sampling in patients at increased risk for endometrial pathology. Management is individualized and stepwise, prioritizing medical therapy with non-hormonal or hormonal options based on etiology, symptom severity, and reproductive goals. Surgical and interventional treatments are reserved for refractory cases or severe bleeding. Special populations, including adolescents, perimenopausal women, and patients with bleeding disorders or on anticoagulation therapy, require tailored strategies and close follow-up.
Full text
2,447 characters
· extracted from
oa-doi-fallback
· click to expand
Abnormal Uterine Bleeding: Diagnostic and Therapeutic Approach
Description
Abnormal uterine bleeding is a frequent gynecological condition with a significant impact on women’s health across the lifespan. It arises from complex alterations in normal menstrual physiology, including hormonal imbalance, impaired endometrial hemostasis, abnormal angiogenesis, and structural uterine pathology. Under physiological conditions, coordinated fluctuations of estrogen and progesterone regulate endometrial proliferation, differentiation, and shedding, while effective hemostatic mechanisms limit menstrual blood loss. Disruption of these processes leads to excessive, irregular, or prolonged bleeding. Clinically, abnormal uterine bleeding may present as acute or chronic disease, a distinction that guides diagnostic urgency and therapeutic decision-making. Its etiology varies according to age, with ovulatory dysfunction predominating in adolescents and younger women, and structural causes such as polyps, fibroids, and adenomyosis becoming more prevalent during the perimenopausal period. Postmenopausal bleeding warrants particular attention because of its association with endometrial malignancy. The FIGO PALM–COEIN classification system provides a standardized framework to distinguish structural from non-structural causes and supports a systematic diagnostic approach. Evaluation of abnormal uterine bleeding relies on detailed clinical history, characterization of bleeding patterns, physical and gynecological examination, and identification of red flags suggestive of malignancy. Diagnostic assessment integrates laboratory testing to exclude anemia and systemic disorders, imagingprimarily transvaginal ultrasoundto identify structural abnormalities, and endometrial sampling in patients at increased risk for endometrial pathology. Management is individualized and stepwise, prioritizing medical therapy with non-hormonal or hormonal options based on etiology, symptom severity, and reproductive goals. Surgical and interventional treatments are reserved for refractory cases or severe bleeding. Special populations, including adolescents, perimenopausal women, and patients with bleeding disorders or on anticoagulation therapy, require tailored strategies and close follow-up.
Files
iaim_2026_1303_15.pdf
Files
(502.2 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:ae3cc6fa54b29cb036c3ecc4b5ea77db
|
502.2 kB | Preview Download |
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.